SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-165118
Filing Date
2019-06-04
Accepted
2019-06-04 17:07:32
Documents
1
Effectiveness Date
2019-06-04

Document Format Files

Seq Description Document Type Size
1 DEFA14A d760521ddefa14a.htm DEFA14A 17502
  Complete submission text file 0001193125-19-165118.txt   18536
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33093 | Film No.: 19877508
SIC: 2834 Pharmaceutical Preparations